Why the study?
Does systemic administration of U-46619 and SNAP induce vasomotion in the retinal network of anesthetized rats?
Does systemic administration of U-46619 and SNAP induce vasomotion in the retinal network of anesthetized rats?
Laser speckle imaging combined with wavelet analysis can successfully detect and track spontaneous and drug-induced vasomotion in the intact rat retina in vivo.
Supports feasibility of laser speckle imaging for retinal vasomotion in rats; leaves open translation to human applications.
Vasomotion is spontaneous or induced rhythmic changes in vascular tone or vessel diameter that lead to rhythmic changes in flow. While the vascular research community debates the physiological and pathophysiological consequence of vasomotion, there is a great need for experimental techniques that can address the role and dynamical properties of vasomotion in vivo. We apply laser speckle imaging to study spontaneous and drug induced vasomotion in retinal network of anesthetized rats. The results reveal a wide variety of dynamical patterns. Wavelet-based analysis shows that (i) spontaneous vasomotion occurs in anesthetized animals and (ii) vasomotion can be initiated by systemic administration of the thromboxane analogue U-46619 and the nitric-oxide donor S-nitroso-acetylDL-penicillamine (SNAP). Although these drugs activate different cellular pathways responsible for vasomotion, our approach can track the dynamical changes they cause.
No takes yet. Share an insight, caveat, or question.
Neganova et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: